IO Biotech holds a performance score of 12 on a scale of zero to a hundred. The company owns a Beta (Systematic Risk) of 0.55, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, IO Biotech's returns are expected to increase less than the market. However, during the bear market, the loss of holding IO Biotech is expected to be smaller as well. Use IO Biotech standard deviation, expected short fall, period momentum indicator, as well as the relationship between the maximum drawdown and rate of daily change , to analyze future returns on IO Biotech.
Risk-Adjusted Performance
Good
Weak
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in IO Biotech are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting fundamental drivers, IO Biotech unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
If you would invest 37.00 in IO Biotech on September 29, 2025 and sell it today you would earn a total of 37.00 from holding IO Biotech or generate 100.0% return on investment over 90 days. IO Biotech is currently generating 1.521% in daily expected returns and assumes 9.5508% risk (volatility on return distribution) over the 90 days horizon. In different words, 85% of stocks are less volatile than IOBT, and 70% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
Expected Return
Risk
Given the investment horizon of 90 days IO Biotech is expected to generate 13.52 times more return on investment than the market. However, the company is 13.52 times more volatile than its market benchmark. It trades about 0.16 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of risk.
IO Biotech Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for IO Biotech's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as IO Biotech, and traders can use it to determine the average amount a IO Biotech's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1593
Best Portfolio
Best Equity
Good Returns
Average Returns
IOBT
Small Returns
Cash
Small Risk
Average Risk
High Risk
Huge Risk
Negative Returns
Based on monthly moving average IO Biotech is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of IO Biotech by adding it to a well-diversified portfolio.
IO Biotech Fundamentals Growth
IOBT Stock prices reflect investors' perceptions of the future prospects and financial health of IO Biotech, and IO Biotech fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on IOBT Stock performance.
Assessing IO Biotech's fundamental ratios provides investors with valuable insights into IO Biotech's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the IO Biotech is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about IO Biotech performance evaluation
Checking the ongoing alerts about IO Biotech for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for IO Biotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
IO Biotech has some characteristics of a very speculative penny stock
IO Biotech appears to be risky and price may revert if volatility continues
Net Loss for the year was (95.49 M) with loss before overhead, payroll, taxes, and interest of (2.59 M).
IO Biotech currently holds about 170.12 M in cash with (82.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.9, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
IO Biotech has a frailfinancial position based on the latest SEC disclosures
Evaluating IO Biotech's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate IO Biotech's stock performance include:
Analyzing IO Biotech's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether IO Biotech's stock is overvalued or undervalued compared to its peers.
Examining IO Biotech's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
Evaluating IO Biotech's management team can have a significant impact on its success or failure. Reviewing the track record and experience of IO Biotech's management team can help you assess the Company's leadership.
Pay attention to analyst opinions and ratings of IO Biotech's stock. These opinions can provide insight into IO Biotech's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating IO Biotech's stock performance is not an exact science, and many factors can impact IO Biotech's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Additional Tools for IOBT Stock Analysis
When running IO Biotech's price analysis, check to measure IO Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IO Biotech is operating at the current time. Most of IO Biotech's value examination focuses on studying past and present price action to predict the probability of IO Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IO Biotech's price. Additionally, you may evaluate how the addition of IO Biotech to your portfolios can decrease your overall portfolio volatility.